$BLGO

BIOLARGO, INC.

BioLargo develops and commercializes cleantech technologies addressing air quality, water treatment, environmental engineering, battery energy storage, and medical applications. It operates through subsidiaries focused on odor and volatile organic compound control, water treatment equipment and solutions, Cellinity battery systems, medical products, professional engineering services, and research and development. BioLargo is headquartered in Westminster, California, with research facilities in Edmonton, Canada, and an engineering team in Oak Ridge, Tennessee. BioLargo earns money by selling odor-control products and providing related installation, maintenance, and support services; selling water treatment products and services; and selling medical products through wholesale distributors and sales agents. Its engineering subsidiary provides fee-based services to outside clients and supports internal projects. The company also licenses technology and receives royalties under commercial arrangements. Cellinity is being developed for long-duration energy storage, while its AEC system treats PFAS-contaminated water and its AROS technology supports industrial water reuse.

0
2
0

No SEC Form 4 filings for $BLGO in the last 30 days.

See all $BLGO insider activity →
Med

BioLargo Reports Third Quarter 2026 Results, Forecasting Commercial Breakout in 2027

BioLargo, Inc. (BLGO) reported Q3 2026 results with revenue at $1.09M, down 1% YoY, and net loss at $3.82M, down 47% YoY. Clyra Medical, a subsidiary, drove 57% of the nine-month net loss. The company launched consumer products under the 'barebird' brand and is preparing for a 2027 product line rollout. BioLargo's AEC PFAS treatment is being validated and has seen increased interest from potential partners.

BioLargo, Inc: BioLargo's BEST Expands Industrial PFAS Treatment Activities Amid Major PFAS Settlements

BioLargo, Inc. (BLGO) announced its subsidiary BEST is conducting two paid PFAS treatment pilots for industrial clients, expanding its commercial pipeline. The pilots use BEST's AEC technology to evaluate treatment performance. Recent PFAS settlements highlight financial exposure and treatment needs, with 3M and DuPont committing billions to resolve claims. BEST's work includes municipal and industrial applications, with a focus on water reuse and remediation.

A new online brand from BioLargo sells pet and laundry odor products.

BioLargo, Inc. (OTCQX:BLGO) launched its direct-to-consumer website for the new barebird™ brand, selling pet and laundry odor products. The brand is licensed to use BioLargo's CupriDyne technology. CEO Dennis Calvert expressed excitement about the brand's potential, comparing it to their successful Pooph brand on Amazon. BioLargo CPG LLC, a subsidiary, owns the barebird brand and plans to expand its product line.

BLGO sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning BLGO (BIOLARGO, INC.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.

Recent BLGO coverage spans financial news, earnings and technology.

What's driving BLGO

AlphAI scores every news story that mentions BLGO with an AI model for sentiment and relevance, and aggregates insider trades from BIOLARGO, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BLGO

Score

BioLargo Reports Third Quarter 2026 Results, Forecasting Commercial Breakout in 2027

BioLargo, Inc. (BLGO) reported Q3 2026 results with revenue at $1.09M, down 1% YoY, and net loss at $3.82M, down 47% YoY. Clyra Medical, a subsidiary, drove 57% of the nine-month net loss. The company launched consumer products under the 'barebird' brand and is preparing for a 2027 product line rollout. BioLargo's AEC PFAS treatment is being validated and has seen increased interest from potential partners.

BioLargo, Inc: BioLargo's BEST Expands Industrial PFAS Treatment Activities Amid Major PFAS Settlements

BioLargo, Inc. (BLGO) announced its subsidiary BEST is conducting two paid PFAS treatment pilots for industrial clients, expanding its commercial pipeline. The pilots use BEST's AEC technology to evaluate treatment performance. Recent PFAS settlements highlight financial exposure and treatment needs, with 3M and DuPont committing billions to resolve claims. BEST's work includes municipal and industrial applications, with a focus on water reuse and remediation.

A new online brand from BioLargo sells pet and laundry odor products.

BioLargo, Inc. (OTCQX:BLGO) launched its direct-to-consumer website for the new barebird™ brand, selling pet and laundry odor products. The brand is licensed to use BioLargo's CupriDyne technology. CEO Dennis Calvert expressed excitement about the brand's potential, comparing it to their successful Pooph brand on Amazon. BioLargo CPG LLC, a subsidiary, owns the barebird brand and plans to expand its product line.

More than $125 million in sales came from Pooph odor products. BioLargo is launching its own brand.

BioLargo (BLGO) launched barebird, a consumer brand for its CupriDyne odor-elimination technology. The brand includes pet and laundry odor products, with initial sales expected through direct-to-consumer channels and later on Amazon and TikTok Shop. BioLargo partners with marketing teams experienced with the Pooph brand, which generated over $125 million in sales.

Related tickers